Synthesis, Characterization, and Cytotoxicity Evaluation of Chlorambucil-Functionalized Mesoporous Silica Nanoparticles
| dc.contributor.author | Karnopp, Juliana Camila Fischer | |
| dc.contributor.author | Jorge, Juliana | |
| dc.contributor.author | da Silva, Jaqueline Rodrigues | |
| dc.contributor.author | Boldo, Diego | |
| dc.contributor.author | Del Pino Santos, Kristiane Fanti | |
| dc.contributor.author | Duarte, Adriana Pereira | |
| dc.contributor.author | de Castro, Gustavo Rocha [UNESP] | |
| dc.contributor.author | de Azevedo, Ricardo Bentes | |
| dc.contributor.author | Prada, Ariadna Lafourcade | |
| dc.contributor.author | Amado, Jesús Rafael Rodríguez | |
| dc.contributor.author | Martines, Marco Antonio Utrera | |
| dc.contributor.institution | Federal University of Mato Grosso do Sul | |
| dc.contributor.institution | University of Brasilia | |
| dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
| dc.contributor.institution | Federal University of Grande Dourados | |
| dc.date.accessioned | 2025-04-29T20:13:49Z | |
| dc.date.issued | 2024-08-01 | |
| dc.description.abstract | This study describes the synthesis and characterization of chlorambucil (CLB)-functionalized mesoporous silica nanoparticles (MSNs) for potential application in cancer therapy. The nanoparticles were designed with a diameter between 20 and 50 nm to optimize cellular uptake and avoid rapid clearance from the bloodstream. The synthesis method involved modifying a previously reported technique to reduce particle size. Successful functionalization with CLB was confirmed through various techniques, including Fourier transform infrared spectroscopy (FTIR) and elemental analysis. The cytotoxicity of the CLB-functionalized nanoparticles (MSN@NH2-CLB) was evaluated against human lung adenocarcinoma cells (A549) and colon carcinoma cells (CT26WT). The results suggest significantly higher cytotoxicity of MSN@NH2-CLB compared to unbound CLB, with improved selectivity towards cancer cells over normal cells. This suggests that MSN@NH2-CLB holds promise as a drug delivery system for targeted cancer therapy. | en |
| dc.description.affiliation | Postgraduate Program in Chemistry Chemistry Institute Federal University of Mato Grosso do Sul, Campo Grande, MS | |
| dc.description.affiliation | Postgraduate Program in Nanoscience and Nanotechnology Biological Science Institute University of Brasilia, DF | |
| dc.description.affiliation | Postgraduate Program in Environmental Biotechnology Bioscience Institute Sao Paulo State University, SP | |
| dc.description.affiliation | Postgraduate Program in Biotechnology Faculty of Pharmacy Food and Nutrition Federal University of Mato Grosso do Sul, Campo Grande, MS | |
| dc.description.affiliation | Postgraduate Program in Health Sciences Faculty of Health Sciences Federal University of Grande Dourados, MS | |
| dc.description.affiliationUnesp | Postgraduate Program in Environmental Biotechnology Bioscience Institute Sao Paulo State University, SP | |
| dc.description.sponsorship | Universidade Federal de Mato Grosso do Sul | |
| dc.identifier | http://dx.doi.org/10.3390/pharmaceutics16081086 | |
| dc.identifier.citation | Pharmaceutics, v. 16, n. 8, 2024. | |
| dc.identifier.doi | 10.3390/pharmaceutics16081086 | |
| dc.identifier.issn | 1999-4923 | |
| dc.identifier.scopus | 2-s2.0-85202587855 | |
| dc.identifier.uri | https://hdl.handle.net/11449/308862 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pharmaceutics | |
| dc.source | Scopus | |
| dc.subject | cancer | |
| dc.subject | chlorambucil | |
| dc.subject | cytotoxicity | |
| dc.subject | drug delivery | |
| dc.subject | mesoporous silica | |
| dc.subject | nanocarriers | |
| dc.subject | targeted therapy | |
| dc.title | Synthesis, Characterization, and Cytotoxicity Evaluation of Chlorambucil-Functionalized Mesoporous Silica Nanoparticles | en |
| dc.type | Artigo | pt |
| dspace.entity.type | Publication | |
| unesp.author.orcid | 0000-0001-5755-9049[2] | |
| unesp.author.orcid | 0000-0002-1218-2425[7] | |
| unesp.author.orcid | 0000-0002-2137-9588[8] | |
| unesp.author.orcid | 0000-0001-7574-6219[10] | |
| unesp.author.orcid | 0000-0003-0405-6514[11] |

